Lanoxin 125 (Digoxin)

Digoxin exerts its effect by inhibiting the Na+/K+‑ATPase pump on cardiac cells, leading to increased intracellular sodium. This change reduces the activity of the sodium‑calcium exchanger, causing calcium buildup inside the myocytes, which strengthens heart muscle contraction. Additionally, digoxin enhances vagal tone, slowing conduction through the atrioventricular node and reducing heart rate.

The appropriate dose of Lanoxin 125 is individualized and determined by the prescribing clinician based on the patient’s age, renal function, electrolyte status, and therapeutic response. The prescriber will calculate the dose, often starting with a low amount and adjusting according to serum digoxin concentrations and clinical effect.

Digoxin is classified as Pregnancy Category C, meaning risk cannot be ruled out. It should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. Limited data exist for breastfeeding; the drug does pass into breast milk, so a risk‑benefit assessment is required before use.

To order Lanoxin 125, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, requesting verification of trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lanoxin 125 (digoxin) provides rate control primarily through enhanced vagal tone and a modest positive inotropic effect, which distinguishes it from beta‑blockers and calcium‑channel blockers that reduce heart rate by blocking sympathetic activity. Digoxin is especially useful in patients with concurrent heart failure, whereas beta‑blockers are preferred when no heart‑failure component exists.

Lanoxin 125 tablets should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in a refrigerator or freezer, and keep out of reach of children.

Lanoxin 125 is taken orally as a tablet. The tablet should be swallowed whole with a glass of water and may be taken with or without food, according to the prescriber’s instructions. Consistency in timing each dose helps maintain stable blood levels.

The most serious risks involve digoxin toxicity, which can manifest as life‑threatening cardiac arrhythmias such as ventricular tachycardia, severe bradycardia, or atrioventricular block. Early signs of toxicity include nausea, vomiting, visual disturbances (yellow‑green halos), and confusion, and they require immediate medical evaluation.

Lanoxin 125 is contraindicated in patients with ventricular fibrillation, known hypersensitivity to digoxin, severe conduction disturbances (e.g., second‑ or third‑degree AV block without a pacemaker), and in those with uncontrolled electrolyte abnormalities, particularly severe hypokalemia or hyperkalemia.